Comparative Analysis of the Expression Patterns of Various TNFSF/TNFRSF in Atherosclerotic Plaques

REFERENCES

• Bae E. M., Kim W. J., Suk K., Kang Y. M., Park J. E., Kim W. Y., Choi E. M., Choi B. K., Kwon B. S., Lee W. H. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol. Immunol. 2008; 45: 523–533
   PubMed Web of Science ®Google Scholar
• Barath P., Fishbein M. C., Cao J., Berenson J., Helfant R. H., Forrester J. S. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 1990a; 65: 297–302
   PubMed Web of Science ®Google Scholar
• Barath P., Fishbein M. C., Cao J., Berenson J., Helfant R. H., Forrester J. S. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am. J. Pathol. 1990b; 137: 503–509
   PubMed Web of Science ®Google Scholar
• Bodmer J. L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schroter M., Becker K., Wilson A., French L. E., Browning J. L., MacDonald H. R., Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 1997; 6: 79–88
   PubMed Web of Science ®Google Scholar
• Browning J. L., Sizing I. D., Lawton P., Bourdon P. R., Rennert P. D., Majeau G. R., Ambrose C. M., Hession C., Miatkowski K., Griffiths D. A., Ngam-ek A., Meier W., Benjamin C. D., Hochman P. S. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J. Immunol. 1997; 159: 3288–3298
   PubMed Web of Science ®Google Scholar
• Chen N. J., Huang M. W., Hsieh S. L. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J. Immunol. 2001; 166: 270–276
   PubMed Web of Science ®Google Scholar
• Chinnaiyan A. M., O'Rourke K., Yu G.L., Lyons R. H., Garg M., Duan D. R., Xing L., Gentz R., Ni J., Dixit V. M. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274: 990–992
   PubMed Web of Science ®Google Scholar
• Eissner G., Kirchner S., Lindner H., Kolch W., Janosch P., Grell M., Scheurich P., Andreesen R., Holler E. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J. Immunol. 2000; 164: 6193–6198
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Marsters S. A., Huang R. M., Pitti R. M., Mark D. T., Baldwin D. T., Gray A. M., Dowd A. D., Brush A. D., Heldens A. D., Schow A. D., Goddard A. D., Wood W. I., Baker K. P., Godowski P. J., Ashkenazi A. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 1999; 9: 215–218
   PubMed Web of Science ®Google Scholar
• Haridas V., Shrivastava A., Su J., Yu G. L., Ni J., Liu D., Chen S. F., Ni Y., Ruben S. M., Gentz R., Aggarwal B. B. VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth. Oncogene 1999; 18: 6496–6504
   Google Scholar
• Harrop J. A., Reddy M., Dede K., Brigham-Burke M., Lyn S., Tan K. B., Silverman C., Eichman C., DiPrinzio R., Spampanato J., Porter T., Holmes S., Young P. R., Truneh A. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 1998; 161: 1786–1794
   PubMedGoogle Scholar
• Kaartinen M., Penttila A., Kovanen P. T. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996; 94: 2787–2792
   Google Scholar
• Kang Y. J., Kim W. J., Bae H. U., Kim D. I., Park Y. B., Park J. E., Kwon B. S., Lee W. H. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine 2005; 29: 229–235
   PubMed Web of Science ®Google Scholar
• Kim J. D., Choi B. K., Bae J. S., Lee U. H., Han I. S., Lee H. W., Youn B. S., Vinay D. S., Kwon B. S. Cloning and characterization of GITR ligand. Genes Immun. 2003; 4: 564–569
   PubMed Web of Science ®Google Scholar
• Kim S. H., Lee W. H., Kwon B.S., Oh G. T., Choi Y. H., Park J. E. Tumor necrosis factor receptor superfamily 12 may destabilize atherosclerotic plaques by inducing matrix metalloproteinases. Jpn. Circ. J. 2001; 65: 136–138
   Google Scholar
• Kim W. J., Bae E. M., Kang Y. J., Bae H. U., Hong S. H., Lee J., Park J. E., Kwon B. S., Suk K., Lee W. H. Glucocorticoid-induced TNFR family-related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006; 119: 421–429
   PubMed Web of Science ®Google Scholar
• Kim W. J., Lee W. H. LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Network 2004; 4: 116–122
   Google Scholar
• Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch. A Pathol. Anat. Histopathol. 1993; 423: 433–442
   Google Scholar
• Kitson J., Raven T., Jiang Y. P., Goeddel D. V., Giles K. M., Pun K. T., Grinham C. J., Brown R., Farrow S. N. A death-domain-containing receptor that mediates apoptosis. Nature 1996; 384: 372–375
   PubMed Web of Science ®Google Scholar
• Kwon B., Yu KY, Ni J., Yu G. L., Jang I. K., Kim Y. J., Xing L., Liu D., Wang S. X., Kwon B. S. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J. Biol. Chem. 1999; 274: 6056–6061
   PubMed Web of Science ®Google Scholar
• Kwon B. S., Tan K. B., Ni J., Oh K. O., Lee Z. H., Kim K. K., Kim Y. J., Wang S., Gentz R., Yu G. L., Harrop J., Lyn S. D., Silverman C., Porter T. G., Truneh A., Young P. R. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 1997; 272: 14272–14276
   PubMed Web of Science ®Google Scholar
• Laman J. D., de Smet B. J., Schoneveld A., van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol. Today 1997; 18: 272–277
   Google Scholar
• Lee H. S., Shin H. H., Kwon B. S., Choi H. S. Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. J. Cell Biochem. 2003; 88: 1048–1056
   PubMed Web of Science ®Google Scholar
• Lee W. H., Kim S. H., Lee Y., Lee B. B., Kwon B., Song H., Kwon B. S., Park J. E. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 2004–2010
   PubMed Web of Science ®Google Scholar
• Li Z., Mahesh S. P., Kim B. J., Buggage R. R., Nussenblatt R. B. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J. Autoimmun. 2003; 21: 83–92
   PubMed Web of Science ®Google Scholar
• Mach F., Schonbeck U., Sukhova G. K., Bourcier T., Bonnefoy J. Y., Pober J. S., Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 1997; 94: 1931–1936
   PubMed Web of Science ®Google Scholar
• Marsters S. A., Sheridan J. P., Donahue C. J., Pitti R. M., Gray C. L., Goddard A. D., Bauer K. D., Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr. Biol. 1996; 6: 1669–1676
   PubMed Web of Science ®Google Scholar
• Mauri D. N., Ebner R., Montgomery R. I., Kochel K. D., Cheung T. C., Yu G. L., Ruben S., Murphy M., Eisenberg R. J., Cohen G. H., Spear P. G., Ware C. F. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998; 8: 21–30
   PubMed Web of Science ®Google Scholar
• Migone T. S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J. S., Perry J. W., Chen S. F., Zhou J. X., Cho Y. H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H. S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P. A., Ruben S. M., Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002; 16: 479–492
   PubMed Web of Science ®Google Scholar
• Montgomery R. I., Warner M. S., Lum B. J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996; 87: 427–436
   PubMed Web of Science ®Google Scholar
• Morel Y., Schiano de Colella J. M., Harrop J., Deen K. C., Holmes S. D., Wattam T. A., Khandekar S. S., Truneh A., Sweet R. W., Gastaut J. A., Olive D., Costello R. T. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J. Immunol. 2000; 165: 4397–4404
   PubMed Web of Science ®Google Scholar
• Morel Y., Truneh A., Sweet R. W., Olive D., Costello R. T. The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 2001; 167: 2479–2486
   PubMed Web of Science ®Google Scholar
• Nocentini G., Giunchi L., Ronchetti S., Krausz L. T., Bartoli A., Moraca R., Migliorati G., Riccardi C. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 1997; 94: 6216–6221
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis--an inflammatory disease. N Engl. J. Med. 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Rus H. G., Niculescu F., Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247–254
   PubMed Web of Science ®Google Scholar
• Salio M., Cella M., Suter M., Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 1999; 29: 3245–3253
   PubMed Web of Science ®Google Scholar
• Shi G., Luo H., Wan X., Salcedo T. W., Zhang J., Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 2002; 100: 3279–3286
   PubMed Web of Science ®Google Scholar
• Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002; 3: 135–142
   PubMed Web of Science ®Google Scholar
• Shin H. H., Kwon B. S., Choi H. S. Recombinant glucocorticoid induced tumour necrosis factor receptor (rGITR) induced COX-2 activity in murine macrophage Raw 264.7 cells. Cytokine 2002; 19: 187–192
   Google Scholar
• Shin H. H., Lee H. W., Choi H. S. Induction of nitric oxide synthase (NOS) by soluble glucocorticoid induced tumor necrosis factor receptor (sGITR) is modulated by IFN-gamma in murine macrophage. Exp. Mol. Med. 2003; 35: 175–180
   Google Scholar
• Tamada K., Shimozaki K., Chapoval A. I., Zhai Y., Su J., Chen S. F., Hsieh S. L., Nagata S., Ni J., Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 2000; 164: 4105–4110
   PubMed Web of Science ®Google Scholar
• Tan K. B., Harrop J., Reddy M., Young P., Terrett J., Emery J., Moore G., Truneh A. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 1997; 204: 35–46
   PubMed Web of Science ®Google Scholar
• Tone M., Tone Y., Adams E., Yates S. F., Frewin M. R., Cobbold S. P., Waldmann H. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 2003; 100: 15059–15064
   PubMed Web of Science ®Google Scholar
• Uraushihara K., Kanai T., Ko K., Totsuka T., Makita S., Iiyama R., Nakamura T., Watanabe M. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol. 2003; 171: 708–716
   PubMed Web of Science ®Google Scholar
• van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995; 378: 620–623
   PubMed Web of Science ®Google Scholar
• Wan X., Shi G., Semenuk M., Zhang J., Wu J. DcR3/TR6 modulates immune cell interactions. J. Cell. Biochem. 2003; 89: 603–612
   Google Scholar
• Wan X., Zhang J., Luo H., Shi G., Kapnik E., Kim S., Kanakaraj P., Wu J. A TNF family member LIGHT transduces costimulatory signals into human T cells. J Immunol 2002; 169: 6813–6821
   PubMed Web of Science ®Google Scholar
• Warner S. J., Libby P. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol. 1989; 142: 100–109
   PubMed Web of Science ®Google Scholar
• Yu K. Y., Kim H. S., Song S. Y., Min S. S., Jeong J. J., Youn B. S. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem. Biophys. Res. Commun. 2003; 310: 433–438
   PubMed Web of Science ®Google Scholar
• Zhai Y., Guo R., Hsu T. L., Yu G. L., Ni J., Kwon B. S., Jiang G. W., Lu J., Tan J., Ugustus M., Carter K., Rojas L., Zhu F., Lincoln C., Endress G., Xing L., Wang S., Oh K. O., Gentz R., Ruben S., Lippman M. E., Hsieh S. L., Yang D. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 1998; 102: 1142–1151
   PubMedGoogle Scholar
• Zhai Y., Ni J., Jiang G. W., Lu J., Xing L., Lincoln C., Carter K. C., Janat F., Kozak D., Xu S., Rojas L., Aggarwal B. B., Ruben S., Li L. Y., Gentz R., Yu G. L. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J. 1999a; 13: 181–189
   PubMed Web of Science ®Google Scholar
• Zhai Y., Yu J., Iruela-Arispe L., Huang W. Q., Wang Z., Hayes A. J., Lu J., Jiang G., Rojas L., Lippman M. E., Ni J., Yu G. L., Li L. Y. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily. Int. J. Cancer 1999b; 82: 131–136
   Google Scholar
• Zhang J., Salcedo T. W., Wan X., Ullrich S., Hu B., Gregorio T., Feng P., Qi S., Chen H., Cho Y. H., Li Y., Moore P. A., Wu J. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 2001; 107: 1459–1468
   PubMed Web of Science ®Google Scholar